The deadline for new clinical trial abstract submissions has passed. Status notifications will be sent to abstract authors on February 17.

The science-based clinical research program at the AACR Annual Meeting showcases how research continues to transform the lives of cancer patients. 

Opportunities for clinical trial presenters

• Numerous and unique oral presentation opportunities, including:
  • Four Clinical Trials Plenary Sessions offering companion presentations discussing the science behind the trials presented
  • Up to five Clinical Trials Minisymposia
• Poster presentations
• Opportunities for extensive national media coverage through the AACR press program
• Opportunities to publish a manuscript in one of the AACR’s highly regarded journals, including potential simultaneous publication with your abstract presentation
  • Review the FAQ relating to simultaneous publication in the AACR Journals for more information
  • Contact [email protected] with any questions

Clinical Trials Included in the Annual Meeting Program

• Any phase (0, first-in-human, I, II, III, or any combination) abstract from national or international clinical trials
• Trials for solid tumors or blood cancers in adult and pediatric patients
• Promising ongoing trials, or unique trial designs that have not yet yielded results (Clinical Trials in Progress)
• Encore clinical trials presentations that have been presented solely in abstract form, including publication in conference proceedings. Encore presentations include significant additional data from the previous presentation (as determined by the AACR Clinical Trials Committee).

EMBARGO POLICY AND ONLINE PUBLICATION OF ABSTRACTS 

• In accordance with the AACR’s embargo policy, the content of abstracts must be kept confidential until they are made publicly available:   
  • The titles and authors of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner no earlier than 4:30 p.m. U.S. ET on Tuesday, March 17, 2025. (Abstract Texts are Embargoed until 12 p.m. U.S. PT on Friday, April 17, 2026.)  
  • The full text of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner and the Meeting App no earlier than 12 p.m. U.S. PT on Friday, April 17, 2026, except those abstracts that are selected for inclusion in the official AACR press program. Abstracts that are featured in the official AACR press program will be made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.